Sommaire

• • ·Challenge of identifying patients with diabetes mellitus who are at low risk for coronary events by use of cardiac stress imaging

    Page :561-563

    Masoor Kamalesh, Harvey Feigenbaum, Stephen Sawada

    Plan Plan
• • ·Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data

    Page :564-572

    Henry R Black

    Résumé Résumé Plan Plan  
• • ·To transfer or not to transfer: acute myocardial infarction reperfusion

    Page :573-574

    Manesh R Patel, Paul W Armstrong

    Plan Plan
• • ·Report of the national heart, lung and blood institute-national institute of allergy and infectious diseases working group on antimicrobial strategies and cardiothoracic surgery

    Page :575-581

    Franklin D Lowy, John A Waldhausen, Marissa Miller, George Sopko, Yves Rosenberg, Sonia I Skarlatos

    Résumé Résumé Plan Plan  
• • ·Increasing rates of cardiac device infections among medicare beneficiaries: 1990–1999

    Page :582-586

    Christopher H Cabell, Paul A Heidenreich, Vivian H Chu, Christopher M Moore, Martin E Stryjewski, G.Ralph Corey, Vance G Fowler

    Résumé Résumé Plan Plan  
• • ·Current and new antimicrobial agents

    Page :587-592

    George M Eliopoulos

    Résumé Résumé Plan Plan
• • ·Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines

    Page :593-598

    John B Robbins, Rachel Schneerson, Gary Horwith, Robert Naso, Ali Fattom

    Résumé Résumé Plan Plan  
• • ·Novel approaches to clinical trials: device-related infections

    Page :599-604

    Robert M Califf, Vance Fowler, Christopher H Cabell, G.Ralph Corey

    Résumé Résumé Plan Plan  
• • ·Highlights from the American Heart Association annual scientific sessions 2003: November 9 to 12, 2003

    Page :605-606

    Jean-Pierre Dery, Manesh R Patel, Svati H Shah, Trip J Meine, Jonathan Yager, Mat Lotfi, Adrian F Hernandez, John L Petersen

    Plan Plan
• • ·Index

    Page :606-607

    Plan Plan
• • ·Index

    Page :607-608

    Plan Plan
• • ·Index

    Page :608-609

    Plan Plan
• • ·Index

    Page :608

    Plan Plan
• • ·Index

    Page :610-611

    Plan Plan
• • ·Index

    Page :611-612

    Plan Plan
• • ·Index

    Page :612-613

    Plan Plan
• • ·Index

    Page :613-614

    Plan Plan
• • ·Index

    Page :613-614

    Plan Plan
• • ·Clinically important differences in health status for patients with heart disease: an expert consensus panel report

    Page :615-622

    Kathleen W Wyrwich, John A Spertus, Kurt Kroenke, William M Tierney, Ajit N Babu, Fredric D Wolinsky

    Résumé Résumé Plan Plan  
• • ·Renal insufficiency and mortality from acute coronary syndromes

    Page :623-629

    Frederick A Masoudi, Mary E Plomondon, David J Magid, Anne Sales, John S Rumsfeld

    Résumé Résumé Plan Plan  
• • ·Differences in care-seeking behavior for acute chest pain in the United States and Japan

    Page :630-635

    Lawrence Liao, David J Whellan, Katsuhiko Tabuchi, Kevin A Schulman

    Résumé Résumé Plan Plan
• • ·A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial

    Page :636-643

    Johann Auer, Thomas Weber, Robert Berent, Rudolf Puschmann, Peter Hartl, Choi-Keung Ng, Christian Schwarz, Ernst Lehner, Ulrike Strasser, Elisabeth Lassnig, Gudrun Lamm, Bernd Eber

    Résumé Résumé Plan Plan  
• • ·External loop recorders: determinants of diagnostic yield in patients with syncope

    Page :644-648

    Lorne J Gula, Andrew D Krahn, David Massel, Allan Skanes, Raymond Yee, George J Klein

    Résumé Résumé Plan Plan  
• • ·Long-term prognosis of inducible ventricular flutter: not an innocent finding

    Page :649-654

    Osnat Gurevitz, Sami Viskin, Michael Glikson, Karla V Ballman, A.Gabriela Rosales, Win-Kuang Shen, Stephen C Hammill, Paul A Friedman

    Résumé Résumé Plan Plan  
• • ·Subcutaneous enoxaparin with early invasive strategy in patients with acute coronary syndromes

    Page :655-661

    J.P Collet, G Montalescot, J.L Golmard, M.L Tanguy, A Ankri, R Choussat, F Beygui, G Drobinski, N Vignolles, D Thomas

    Résumé Résumé Plan Plan  
• • ·Long-term effects of quinapril with high affinity for tissue angiotensin-converting enzyme after coronary intervention in Japanese

    Page :662-668

    Masaya Otsuka, Hideya Yamamoto, Tomokazu Okimoto, Yoshihiro Dohi, Shinji Mito, Yukihiko Gomyo, Takashi Fujii, Wataru Matsuura, Yukoh Hirai, Nobuoki Kohno

    Résumé Résumé Plan Plan  
• • ·L-arginine supplementation does not inhibit neointimal formation after coronary stenting in human beings: an intravascular ultrasound study

    Page :668

    Dariusz Dudek, Jacek Legutko, Grzegorz Heba, Stanislaw Bartus, Lukasz Partyka, Ihor Huk, Aldona Dembinska-Kiȩc, Grzegorz L Kaluza, Jacek S Dubiel

    Résumé Résumé Plan Plan  
• • ·Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial

    Page :669-675

    Abhiram Prasad, Gregg W Stone, Eve Aymong, Peter J Zimetbaum, Michael McLaughlin, Roxana Mehran, Eulogio Garcia, James E Tcheng, David A Cox, Cindy L Grines, Bernard J Gersh

    Résumé Résumé Plan Plan  
• • ·Randomized comparison of direct stenting with predilatation followed by stenting on vessel trauma and restenosis

    Page :675

    Rainer Hoffmann, Mefaret Takimoglu-Boerekci, Roswitha Langenberg, Christian Knackstedt, Andreas Franke, Peter W Radke, Peter Hanrath

    Résumé Résumé Plan Plan  
• • ·Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction

    Page :676

    Hideaki Kurihara, Satoru Matsumoto, Ritsu Tamura, Kenji Yachiku, Atsuyuki Nakata, Tsutomu Nakagawa, Takashi Yoshino, Tatsuo Matsuyama

    Résumé Résumé Plan Plan  
• • ·A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation

    Page :676

    Craig P Juergens, Adelina M Wong, Dominic Y.C Leung, Harry C Lowe, Sidney Lo, Clyne Fernandes, Elizabeth F Newland, Andrew P Hopkins

    Résumé Résumé Plan Plan
• • ·The diabetic postoperative mortality and morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery

    Page :677-683

    Anne Benedicte Juul, Jørn Wetterslev, Allan Kofoed-Enevoldsen, Torben Callesen, Gorm Jensen, Christian Gluud, DIPOM Group *

    Résumé Résumé Plan Plan  
• • ·Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the facilitated intervention with enhanced reperfusion speed to stop events (FINESSE) trial

    Page :684

    Stephen G Ellis, Paul Armstrong, Amadeo Betriu, Bruce Brodie, Howard Herrmann, Gilles Montalescot, Franz-Josef Neumann, John J Smith, Eric Topol, FINESSE Investigators

    Résumé Résumé Plan Plan  
• • ·Correction

    Page :684

    
• • ·Apolipoprotein E ϵ4 allele is associated with left ventricular systolic dysfunction

    Page :685-689

    Gysèle S Bleumink, Cornelia M van Duijn, J.Herre Kingma, Jacqueline C.M Witteman, Albert Hofman, Bruno H.Ch Stricker

    Résumé Résumé Plan Plan
• • ·Recent and temporal trends (1975 to 1999) in the treatment, hospital, and long-term outcomes of hispanic and non-hispanic white patients hospitalized with acute myocardial infarction: a population-based perspective

    Page :690-697

    Jorge Yarzebski, Carmen F Bujor, Darleen Lessard, Joel M Gore, Robert J Goldberg

    Résumé Résumé Plan Plan  
• • ·Variable inhibition of high-shear–induced platelet plug formation by eptifibatide and tirofiban under conditions of platelet activation and high von willebrand release: a randomized, placebo-controlled, clinical trial

    Page :697

    Ulla Derhaschnig, Christine Pachinger, Bernd Jilma

    Résumé Résumé Plan Plan  
• • ·Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction

    Page :698-704

    Arthur C.P Maas, Christina M Wyatt, Cynthia L Green, Galen S Wagner, Kathleen M Trollinger, James E Pope, Anatoly Langer, Paul W Armstrong, Robert M Califf, Maarten L Simoons, Mitchell W Krucoff

    Résumé Résumé Plan Plan  
• • ·Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study

    Page :705-712

    Herbert Schuster, Philip J Barter, Steen Stender, Raphael C Cheung, Jacques Bonnet, Jonathan M Morrell, Claire Watkins, David Kallend, Ali Raza, MERCURY I Study Group

    Résumé Résumé Plan Plan  
• • ·Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors

    Page :713

    James H Stein, Michelle A Merwood, Jennifer L Bellehumeur, Susan E Aeschlimann, Claudia E Korcarz, Gail L Underbakke, Maureen E Mays, James M Sosman

    Résumé Résumé Plan Plan
• • ·Relationship of myocardial perfusion imaging findings to outcome of patients with heart failure and suspected ischemic heart disease

    Page :714-720

    Wayne L Miller, David O Hodge, Susan K Tointon, Richard J Rodeheffer, Susan M Nelson, Raymond J Gibbons

    Résumé Résumé Plan Plan  
• • ·Reproducibility of the proximal flow convergence method in mitral and tricuspid regurgitation

    Page :721-728

    Georg Grossmann, Albrecht Hoffmeister, Armin Imhof, Martin Giesler, Vinzenz Hombach, Jochen Spiess

    Résumé Résumé Plan Plan  
• • ·Changes in systemic sympathetic nervous system activity after mitral valve surgery and their relationship to changes in left ventricular size and systolic performance in patients with mitral regurgitation

    Page :729-735

    Rajendra H Mehta, Mark A Supiano, P.Michael Grossman, Hakan Oral, Daniel G Montgomery, Kerri A Briesmiester, Marla J Smith, Mark R Starling

    Résumé Résumé Plan Plan  
• • ·Dilatation of the aorta in pure, severe, bicuspid aortic valve stenosis

    Page :736-740

    Gareth J Morgan-Hughes, Carl A Roobottom, Patrick E Owens, Andrew J Marshall

    Résumé Résumé Plan Plan  
• • ·Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: symptomatic cardiac obstruction–pilot study of enalapril in aortic stenosis (SCOPE-AS)

    Page :740

    Anand Chockalingam, S Venkatesan, T Subramaniam, V Jagannathan, S Elangovan, R Alagesan, G Gnanavelu, Smrita Dorairajan, B.P Krishna, V Chockalingam

    Résumé Résumé Plan Plan  
• • ·Evaluation of atrial refractoriness immediately after percutaneous mitral balloon commissurotomy in patients with mitral stenosis and sinus rhythm

    Page :741-745

    Mustafa Soylu, Ahmet Duran Demir, Özcan Özdemir, Serkan Topaloğlu, Dursun Aras, Erdal Duru, Ali Şaşmaz, Şule Korkmaz

    Résumé Résumé Plan Plan  
• • ·Mortality in primary and secondary myocarditis

    Page :746-750

    Todd C Pulerwitz, Thomas P Cappola, G.Michael Felker, Joshua M Hare, Kenneth L Baughman, Edward K Kasper

    Résumé Résumé Plan Plan  
• • ·Table of contents

    Page :A2

    Plan Plan
• • ·Editorial board

    Page :A6

    
• • ·Information for authors

    Page :A7

    
• • ·Information for readers

    Page :A9

    Plan Plan